ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,342.44
1.69%
S&P 500
5,300.87
0.07%
Dow Jones
39,904.07
0.09%
US Dollar vs Yen
155.745
0.23%
Brent Oil
83.11
-0.11%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Achillion Pharmaceuticals Inc (ACHN)

  7. Achillion Pharmaceuticals Inc (ACHN) ニュース

ACHN

Achillion Pharmaceuticals (ACHN)

Achillion Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:ACHN
日付受信時刻ニュースソース見出しコード企業名
2020/02/1506 : 55Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2020/02/1503 : 29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2020/02/1300 : 27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2020/02/1221 : 58Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2020/02/1021 : 34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2020/02/0720 : 11Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2020/02/0320 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2020/02/0320 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2020/02/0320 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2020/02/0320 : 00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/12/1923 : 24GlobeNewswire Inc.Achillion Shareholders Approve Agreement to be Acquired by AlexionNASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/12/1000 : 00GlobeNewswire Inc.Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who...NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/11/2300 : 42PR Newswire (US)Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corpor...NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/11/1921 : 30GlobeNewswire Inc.European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients...NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/11/1121 : 30GlobeNewswire Inc.Achillion Announces Clearance of Investigational New Drug Application for ACH-5228NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/11/0806 : 20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/11/0806 : 18Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/11/0806 : 08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/11/0721 : 30GlobeNewswire Inc.Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/11/0623 : 07GlobeNewswire Inc.Achillion Announces Data Presentations at the 61st American Society of Hematology Annual MeetingNASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/11/0607 : 07Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/11/0205 : 23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/10/1906 : 14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/10/1905 : 50PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc.NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/10/1806 : 09Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/10/1705 : 55Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/10/1623 : 44PR Newswire (US)Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Achillion Pharmaceuticals, Inc. has obtained a Fair Price in it...NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/10/1621 : 54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/10/1621 : 52Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACHNAchillion Pharmaceuticals Inc
2019/10/1621 : 50PR Newswire (US)Achillion (ACHN) Alert: Johnson Fistel Investigates Proposed Sale of Achillion Pharmaceuticals; Are Shareholders Getting a Fa...NASDAQ:ACHNAchillion Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACHN

最近閲覧した銘柄

NYSE
XOM
Exxon Mobil
AMEX
XLV
Health Care Select Sector
NYSE
BAC
Bank of America
NYSE
DIS
Walt Disney
NYSE
JPM
JP Morgan Chase
CCOM
US30
US 30
NASDAQ
AMZN
Amazon.com
NASDAQ
NVDA
NVIDIA
NYSE
VZ
Verizon Communications
NASDAQ
GOOGL
Alphabet
FX
USDEUR
US Dollar vs Euro
USOTC
RHHBY
Roche (QX)
COIN
ETHUSD
Ethereum
CCOM
SILVER
SILVER
NASDAQ
MSFT
Microsoft
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有